TY  - RPRT
TI  - The clinical drug candidate ebselen attenuates inflammation and promotes microbiome recovery after antibiotic treatment for Clostridium difficile infection
AU  - Garland, M.
AU  - Hryckowian, A. J.
AU  - Tholen, M.
AU  - Loscher, S.
AU  - Van Treuren, W. W.
AU  - Oresic Bender, K.
AU  - Sonnenburg, J. L.
AU  - Bogyo, M.
PY  - 2019
DO  - 10.1101/827329
UR  - https://www.biorxiv.org/content/10.1101/827329v1
ID  - 10.1101/827329
ER  -